Report overview
This report contains market size and forecasts of Vero Cell Rabies Vaccines for Human in global, including the following market information:
Global Vero Cell Rabies Vaccines for Human Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vero Cell Rabies Vaccines for Human Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Vero Cell Rabies Vaccines for Human companies in 2021 (%)
The global Vero Cell Rabies Vaccines for Human market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Freeze-dried Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vero Cell Rabies Vaccines for Human include Bharat Biotech, Sanofi-Pasteur, Chengda Bio, Prcmise, Zhuoyi Biological, Ningbo Rongan Biological and Indian Immunologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Vero Cell Rabies Vaccines for Human manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vero Cell Rabies Vaccines for Human Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vero Cell Rabies Vaccines for Human Market Segment Percentages, by Type, 2021 (%)
Freeze-dried Powder
Liquid
Global Vero Cell Rabies Vaccines for Human Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vero Cell Rabies Vaccines for Human Market Segment Percentages, by Application, 2021 (%)
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Global Vero Cell Rabies Vaccines for Human Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vero Cell Rabies Vaccines for Human Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vero Cell Rabies Vaccines for Human revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vero Cell Rabies Vaccines for Human revenues share in global market, 2021 (%)
Key companies Vero Cell Rabies Vaccines for Human sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Vero Cell Rabies Vaccines for Human sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
